Case studies

There are a range of case studies available below which illustrate the diversity of ongoing collaborations between the pharmaceutical industry and academic researchers in the UK, and how these can accelerate the development of new medicines and vaccines for patients. We hope these provide inspiration for how you could get involved!

Non-specific partnership:
The Rare Disease Consortium

Non-specific partnership:
Innovative Medicines Initiative

Equipment / resources:
UCB's Antibody Technology Access Platform

Non-specific partnership:
Novo Nordisk and University of Oxford

Equipment / resources:
GSK's Immunology Catalyst

Equipment / resources:
Cambridge Pharmaceutical Cryo-EM Consortium

Investigator initiated studies:
GSK-Cambridge Alliance for clinical research

Non-specific partnership:
The European Paediatric Formulation Initiative

Non-specific partnership:
Eisai-UCL - a long term strategic partnership

Equipment / resources:
CRUK-MedImmune Alliance Laboratory

Equipment / resources:
Discovery Partnerships with Academia

Compounds:
Compound sharing - AZ and Manchester